Asia Pacific Precision Oncology Summit 2024

Join the Agilent Precision Oncology Summit to explore the latest in personalized cancer treatment. This year the summit begins with offering cutting-edge insights and practical guidance to enhance cancer care precision and effectiveness. Stay ahead in oncology and improve patient outcomes with precision medicine.

• Evaluation of PD-L1 in Gastric Cancer, Dr Chen Xiu Fen, Associate Consultant Pathologist, Singapore General Hospital, Singapore.
• Current and Emerging Biomarkers in Gastric Cancer Management – A Pathologist’s Perspective, Dr Brendan Pang, Consultant Pathologist, Avant-Garde Pathology, Singapore.
• Understanding PDL1 Assessment: Insights from Breast and Cervical Cancer Specimens, Dr Philippe Taniere, Consultant Histopathologist, University Hospitals Birmingham NHS Foundation Trust, United Kingdom.